Advances in Medical Management of Early Stage and Advanced Breast Cancer: 2015

Sabrina Witherby1, Tina Rizack2, Bachir J Sakr2

  • 1Program in Women׳s Oncology, Breast Health Center, Women and Infants Hospital of Rhode Island and Alpert Medical School of Brown University, Providence, RI; Department of Medicine, Memorial Hospital of Rhode Island, Pawtucket, RI.

Insights

Recent advances in breast cancer systemic therapy, driven by biological insights and clinical trials, offer improved outcomes and reduced toxicity for patients. This review covers key developments, patient subgroups, and future treatment directions.

Area of Science:

  • Oncology
  • Medical Sciences

Background:

  • Breast cancer management has evolved significantly due to increased understanding of disease biology.
  • Recent clinical trials and novel therapeutic agents have improved patient outcomes and reduced treatment toxicity.

Purpose of the Study:

  • To review major recent developments in the systemic therapy of breast cancer.
  • To categorize these advancements by patient subgroups and disease stage.
  • To discuss current treatment controversies and emerging therapies.

Main Methods:

  • Literature review of recent clinical trials and scientific publications.
  • Analysis of systemic therapy advancements in breast cancer.
  • Categorization of findings based on clinical relevance.

Main Results:

  • Significant progress in systemic therapy for early-stage and advanced breast cancer.
  • Novel agents and treatment strategies offer improved efficacy and/or reduced toxicity.
  • Developments are presented across various patient subgroups and disease stages.

Conclusions:

  • Recent advancements have substantially improved breast cancer treatment options.
  • Ongoing research and novel therapies promise further improvements in patient outcomes.
  • Understanding disease biology is crucial for developing effective systemic therapies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
830